Dose-response of n-3 polyunsaturated fatty acids on lipid profile and tolerability in mildly hypertriglyceridemic subjects

Journal of Medicinal Food

Volumn 12, Issue 4, 2009, Pages 803-808

  Park, Yongsoon ^a   Harris, William S ^b,c  

^a Hanyang University   (South Korea)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Hypertriglyceridemia; Lipid profile; N 3 polyunsaturated fatty acids; Postprandial; Tolerability

Indexed keywords

CHYLOMICRON; CORN OIL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; ROPUFA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG TOLERABILITY; ERUCTATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PARALLEL DESIGN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHOSPHOLIPIDS;

ZEA MAYS;

EID: 70149109170     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.1250     Document Type: Article

References (36)

1. Harris WS, Park YS, Isley WL: Cardiovascular disease and long-chain omega-3 fatty acids. Curr Opin Lipidol 2003;14:9-14.
2. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(5 Suppl):S1645-1654S.
3. Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-1209.
4. He K, Song Y, Daviglus MK, Liu K, Van Horn L, Dyer AR, Greenland P: Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004;109:2705-2711.
5. Pounis GD, Panagiotakos DB, Chrysohoou C, Aggelopoulos P, Tsiamis E, Pitsavos C, Stefanadis C: Long-term fish consumption is associated with lower risk of 30-day cardiovascular disease events in survivors from an acute coronary syndrome. Int J Cardiol 2009;136:344-346.
6. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effects of changes in fat, fish, and fiber intakes on death and myocardial re-infarction: Diet and Reinfarction Trial (DART). Lancet 1989; 2:757-761.
7. Kromhout D, Katan M, Havekes L, Groener A, Hornstra G, de Lezenne Coulander C: The effect of 26 years of habitual fish consumption on serum lipid and lipoprotein levels (The Zutphen Study). Nutr Metab Cardiovasc Dis 1996;2:65-71.
8. GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: results of the GISSI-Prevenzione Trial. Lancet 1999;354:447-455.
9. Agren JJ, Hanninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnonen O, Uusitupa M: Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr 1996;50:765-771.
10. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Goldin BR, Rasmussen H, McNamara JR, Ordovas JM: Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am J Clin Nutr 1996;63:234-241.
11. Nilsen DW, Albrektsen G, Landmark, Moen S, Aarsland T, Woie L: Effect of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001;74: 50-56.
12. Roche HM, Gibney MJ: Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation. Eur J Clin Nutr 1996;50:617-624.
13. Lekhal S, Børvik T, Nordøy A, Hansen JB: Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction. Lipids 2008;43:507-515.
14. Lekhal S, Børvik T, Nordøy A, Hansen JB: Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction. Nutr Metab Cardiovasc Dis 2008;18:700-706.
15. Park Y, Harris WS: Dose-dependent effects of n-3 polyunsaturated fatty acids on platelet activation in mildly hypertriglyceri-demic subjects. J Med Food 2009;12:809-813.
16. Mills GL, Lane PA, Weech PK: Laboratory techniques. In: Biochemistry and Molecular Biology (Burdon RH, van Knip-penberg PH, eds.). Elsevier, New York, 1984, p. 62.
17. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 19:499-502.
18. Park Y, Grellner WJ, Harris WS, Miles JM: A new method for the study of chylomicron kinetics in vivo. Am J Physiol 2000; 279:E1258-E1263.
19. Harris WS, Von Schacky C: The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 2004;39: 212-220.
20. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM: Plant-and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 2003;77:783-795.
21. Sirtori CR, Crepaldi G, Manzato E, Mancini M, Rivellese A, Paoletti R, Pazzucconi F, Pamparana F, Stragliotto E: One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced trigly-ceridemia, total cholesterol and increased HDL-C without gly-cemic alterations. Atherosclerosis 1998;137:419-427.
22. Schwellenbach LJ, Olson KL, McConnell KJ, Stolcpart RS, Nash JD, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group: The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr 2006;25:480-485.
23. Davidson MH: Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006;98:27i-33i.
24. Gans RO, Bilo HJ, Weersink EG, Rauwerda JA, Fonk T, Popp-Snijders C, Donker AJ: Fish oil supplementation in patients with stable claudication. Am J Surg 1990;160:490-495.
25. Hansen JB, Olsen JO, Wilsgard L, Lyngmo V, Svensson B: Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men. Eur J Clin Nutr 1993; 47:497-507.
26. Lungerhausen YK, Abbey M, Nestel PJ, Howe PRC: Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens 1994;12:1041-1045.
27. Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, Weiner BH, Slack JD, Kellett MA, Raizner AE, Weber PC, Mahrer PR, Rossouw JE: Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;90:2248-2257.
28. Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L: Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglycer-idaemia. Eur J Clin Nutr 1994;48:859-865.
29. Park Y, Harris WS: Triglyceride-rich lipoprotein margination: a potential surrogate for whole body lipoprotein lipase activity and effects of EPA and DHA. Am J Clin Nutr 2004;80:45-50.
30. Park Y, Harris WS: Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 2003;44: 455-463.
31. Harris WS: N-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996;31:243-252.
32. Radack KL, Deck CC, Huster GA: n-3 fatty acid effects on lipids, lipoproteins, and apolipoproteins at very low doses: results of a randomized controlled trial in hypertriglyceridemic subjects. Am J Clin Nutr 1990;51:599-605.
33. Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE, Sanders TA: LDL cholesterol-raising effect of low-dose docosa-hexaenoic acid in middle-aged men and women. Am J Clin Nutr 2004;79:558-563.
34. Kelley DS, Siegel D, Vemuri M, Mackey BE: Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86: 324-333.
35. Calabresi L, Donati D, Pazzucconi F: Omacor in familial combined hyperlipidemia: effects on lipids and low-density lipoprotein subclasses. Atherosclerosis 2000;148:387-396.
36. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 2008;372:1223-1230.